Event Details

International Commercialization: Sound or Risky Strategy
For Medical Device Companies?

Whether the driver is a lengthy and unpredictable FDA regulatory pathway or growth opportunities in emerging markets, a rising number of medical device companies are evaluating and executing international commercialization strategies. But is expanding outside of the U.S. a sound or risky strategy for young medical device companies?

In this timely program, a panel of experts will discuss the pros and cons of international commercialization. Hear from medical device senior executives who have successfully ventured into overseas markets. Learn why international clinical and commercial strategies are closely linked. Tap into valuable state and local resources that will increase your odds of success.

Greg Davis of MedCelerate Consulting Group will be our Keynote Speaker, with additional speakers to be announced.

Visit: http://www.semda.net for additional information and registration.